Skip to main content
Watch Insiders
Market intelligence
CRVSHealthcare

Corvus Pharmaceuticals Inc insider activity

In the last 90 days, 2 corporate insiders purchased $333,689 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$333,689
Corporate buyers
2
Latest transaction
Jun 11, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 11, 2026David Scott MooreDirectorOpen Market Purchase21,700$11.53$250,236
May 18, 2026Richard A Md MillerPresident and CEOOpen Market Purchase6,932$12.04$83,454